News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current AKBA market cap is 207.23M. The company's latest EPS is USD -0.4913 and P/E is -2.16.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 126.76M | 48.96M | 55.18M | 40.13M | 56.25M |
| Operating Income | 33.9M | -48.17M | -6.35M | -24.94M | -9.66M |
| Net Income | 29.28M | -51.87M | -7.55M | -26.22M | -11.83M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 207.74M | 335M | 295.31M | 213.58M | 292.6M |
| Operating Income | -178.16M | -286.29M | -376.44M | -265.32M | -79.12M |
| Net Income | -143.59M | -279.66M | -383.46M | -282.84M | -92.56M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 521.8M | 435.89M | 351.83M | 276.86M | 253.71M |
| Total Liabilities | 459.5M | 422.04M | 342.49M | 291.21M | 280.52M |
| Total Equity | 62.3M | 13.85M | 9.34M | -14.35M | -26.81M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 996.54M | 771.2M | 644.14M | 525.55M | 351.83M |
| Total Liabilities | 360.61M | 376.44M | 396.52M | 449.09M | 342.49M |
| Total Equity | 635.93M | 394.76M | 247.62M | 76.46M | 9.34M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -52.28M | -18.48M | -73.15M | -17.54M | -13.91M |
| Investing | -114k | -114k | -114k | N/A | N/A |
| Financing | 47.54M | 14.6M | 14.6M | -15.97M | -23.97M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -97.49M | -257.44M | -110.39M | -252.97M | -73.15M |
| Investing | 36.59M | 211.18M | -40M | 39.94M | -114k |
| Financing | 96.56M | 88.97M | 231.72M | 133.73M | 14.6M |
| Market Cap | 207.23M |
| Price to Earnings Ratio | -2.16 |
| Price to Sales Ratio | 0.68 |
| Price to Cash Ratio | 2.21 |
| Price to Book Ratio | 21.38 |
| Dividend Yield | - |
| Shares Outstanding | 188.39M |
| Average Volume (1 week) | 694.83k |
| Average Volume (1 Month) | 1.33M |
| 52 Week Change | 307.56% |
| 52 Week High | 1.84 |
| 52 Week Low | 0.2656 |
| Spread (Intraday) | 0.03 (2.73%) |
| Company Name | Akebia Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.akebia.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
